Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma

Journal of Surgical Oncology

Volumn 82, Issue 4, 2003, Pages 247-255

  Belessi, Chrysoula J ^a,d   Parasi, Aikaterini S ^a   Manioudaki, Helen S ^a   Laoutaris, Nikolaos P ^a   Legakis, Nikolaos C ^b   Peros, Georgios TH ^b   Androulakis, Georgios A ^c  

^a Renal Unit   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d NONE   (Greece)

Author keywords

DNA ploidy; Gastric lymphoma; PCNA; S phase fraction

Indexed keywords

CYCLINE;

ADULT; AGED; ANEUPLOIDY; ARTICLE; B CELL LYMPHOMA; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL FRACTIONATION; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH LYMPHOMA;

ADULT; AGED; AGED, 80 AND OVER; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MALE; MIDDLE AGED; PLOIDIES; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RETROSPECTIVE STUDIES; S PHASE; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 12244304854     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10227     Document Type: Article

References (46)

1. Gospodarowicz MK, Sutcliffe SB: The extranodal lymphomas. Semin Radial Oncol 1995;5:281-300.
2. Freeman C, Berg JW, Cutler SJ: Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29:252-260.
3. Chan JK: Gastrointestinal lymphomas: An overview with emphasis on new findings and diagnostic problems. Semin Diagn Pathol 1996;13:260-296.
4. Radaszkiewicz T, Dragosis B, Bauer P: Gastrointestinal malignant lymphomas of the mucosa-associated lymhoid tissue: Factors relevant to prognosis. Gastroenterology 1992;102:1628-1638.
5. Shipp MA, Mauch PM, Harris NL: Non Hodgkin's lymphomas. In: De Vita VT, Hellman S, Rosenberg SA (eds). Principles and practice of oncology, 5th edition. Philadelphia: Lippincott-Raven. 1997;2165-2220.
6. Isaacson PG, Wright DH: Malignant lymphoma of mucosa-associated lymphoid tissue: A distinctive type of B-cell lymphoma. Cancer 1983;52:1410-1416.
7. Chan JK, Ng CS, Isaacson PG: Relationship between high-grade lymphoma and low-grade B-cell mucosa associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol 1990;136:1153-1164.
8. Castrillo JM, Montalban C, Obeso G, et al.: Gastric B-cell mucosa associated lymphoid tissue lymphoma: A clinico-pathological study in 56 patients. Gut 1992;33:1307-1311.
9. Hayashi K, Motoori T, Nakamura S, et al.: A clinicopathologic study of primary gastric lymphoma of B-cell type among the Japanese with special reference to low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT). Jpn J Gastroenterol 1993;90:2985-2998.
10. Harris NL, Jaffe ES, Stein H, et al.: A reviced European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1372.
11. Jaffe ES, Harris NL, Diebold J, et al.: World Health Organization classification of neoplastic diseases of hematopoietic and lymphoid tissues. A progress report. Am J Clin Pathol 1999;11(Suppl 1):8-12.
12. Harris NL, Jaffe ES, Diebold J, et al.: The World Health Organisation classification of hematological malignancies: Report of the Clinical Advisory Committee, Airlie House, Virginia, November 1997. Mod Pathol 2000;13:193-207.
13. Hall PA, Richards MA, Gregory WM, et al.: The prognostic value of Ki67 immunostaining in non Hodkgin's lymphoma. J Pathol 1988;154:223-235.
14. Roos G, Dige U, Lenner P, et al.: Prognostic significance of DNA analysis by flow cytometry in non Hodkgin's lymphoma. Haematol Oncol 1985;233-242.
15. Woods AL, Hall PA, Shepherd NA, et al.: The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology 1991;19:21-27.
16. Braylan RC: Flow cytometric DNA analysis in the prognosis and diagnosis of lymphomas. Am J Clin Pathol 1993;99:374-380.
17. Okuda A, Suzuki H: Effects of DNA ploidy patterns on the survival of patients with primary gastrointestinal lymphoma. Surg Today 1996;26(8):586-590.
18. Ohashi S, Segawa K, Okamura S, et al.: A clinicopathologic study of gastric mucosa-associated lymphoid tissue lymphoma. Cancer 2000;88:2210-2219.
19. Akaza K, Motoori T, Nakamura S, et al.: Clinicopathologic study of primary gastric lymphoma of B cell phenotype with special reference to low grade B cell lymphoma of mucosa-associated lymphoid tissue among the Japanese. Pathol Int 1995;45:832-845.
20. Aydin Z, Barista I, Canpinar H, et al.: Gastric lymphoma in Turkey. Cancer 2000;89:12-20.
21. Carbone PP, Kaplan HS, Musshoff K, et al.: Report of the committee on Hodgkin's disease staging procedures. Cancer Res 1971;31:1860-1861.
22. Musshoff K: Clinical staging classification of non Hodgkin's lymphomas. Strahlentherapie 1977;153:218-221.
23. Hedley DM, Friedlander ML, Taylor IW, et al.: Method for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-1335.
24. Ormerod MG: Analysis of DNA - General methods. In: Ormerod MG (editor). Flow cytometry: A practical approach. 2nd edition. Oxford: IRL at Oxford University Press. 1994; 119-135.
25. Ormerod MG, Tribukait B, Giaretti W: Consensus report of the task force on standarization of DNA flow cytometry in clinical pathology. Anal Cell Pathol 1998;17:103-110.
26. Hedley DW: Flow cytometry using paraffin-embedded tissue: Five years on. Cytometry 1989;10:229-241.
27. Peto R, Pike MC, Armitage P, et al.: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977;35:1-39.
28. Bauer KD, Merkel DE, Winter JN, et al.: Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomas. Cancer Res 1986;46:3173-3178.
29. Morgan DR, Williamson JM, Quirke P, et al.: DNA content and prognosis of non-Hodgkin's lymphoma. Br J Cancer 1986;54:643-649.
30. Young GA, Hedley DW, Rugg CA, et al.: The prognostic significance of proliferative activity in poor histology non-Hodgkin's lymphoma: A flow cytometry study using archival material. Eur J Cancer Clin Oncol 1987;23:1497-1504.
31. Cowan RA, Harris M, Jones M, et al.: DNA content in high and intermediate grade non-Hodgkin's lymphoma: Prognostic significance and clinicopathological correlations. Br J Cancer 1989;60:904-910.
32. Cavalli C, Danova M, Gobbi PG, et al.: Ploidy and proliferative activity measurement by flow cytometry in non Hodgkin's lymphomas: Do speculative aspects prevail over clinical ones? Eur J Cancer Clin Oncol 1989;25:1755-1763.
33. Joensuu H, Klemi PJ, Soderstrom KO, et al.: Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma. Cancer 1991;68:1564-1571.
34. Christensson B, Lindemalm C, Johansson B, et al.: Flow cytometric DNA analysis: A prognostic tool in non-Hodgkin's lymphoma. Leuk Res 1989;13:307-314.
35. Lehtinen T, Aine R, Leihtinen M, et al.: Flow cytometric DNA analysis of 199 histiologically favorable or unfavorable non-Hodgkin's lymphomas. J Pathol 1989;157:27-36.
36. Joensuu H, Soderstrom KO, Klemi PJ, et al.: Nuclear DNA content and its prognostic value in lymphoma of the stomach. Cancer 1987;60:3942-3048.
37. Coltrera MC, Gown AM: PCNA cyclin expression and BrdUrd uptake define different subpopulations in different cell lines. J Histochem Cytochem 1991;39:23-30.
38. Holte H, Suo Z, Smeland EB, et al.: Prognostic value of lymphoma specific S-phase fraction compared with that of other cell proliferation markers. Acta Oncol 1999;38:495-503.
39. Kedar PS, Kim SJ, Robertson A, et al.: Direct interaction between mammalian DNA polymerase beta and proliferating cell nuclear antigen. J Biol Chem 2002;277:31115-31123.
40. Linden MO, Terres FX, Kubus J, et al.: Clinical application of morphologic and immunocytochemical assessment of cell proliferation. Am J Clin Pathol 1992;5:4-13.
41. Celis JE, Bravo R, Larsen PM, et al.: Cyclin: A nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells. Leuk Res 1984;8:143-157.
42. Bravo R, Frank R, Blundell PA, et al.: Cyclin/PCNA is the auxiliary of DNA polymerase-delta. Nature 1987;326:515-517.
43. Prelich G, Tan C-K, Kostura M, et al.: Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 1987;326:517-520.
44. Hall PA, Levison DA, Woods AL, et al.: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-294.
45. Matsumoto Y: Molecular mechanism of PCNA-dependent base excision repair. Prog Nucleic Acid Res Mol Biol 2001;68:129-138.
46. Isaacson PG: Gastric MALT lymphoma: From concept to cure. Ann Oncol 1999;10:637-645.